Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation
A Alvarez, S Orden, I Andújar, V Collado-Diaz… - Aids, 2017 - journals.lww.com
There is a long-lasting controversy surrounding an association between abacavir (ABC) and
an increased risk of cardiovascular disease in HIV-positive patients. Although differing in …
an increased risk of cardiovascular disease in HIV-positive patients. Although differing in …
Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the …
Background There is ongoing controversy regarding abacavir use in the treatment of HIV
infection and the risk of subsequent development of cardiovascular disease. It is unclear …
infection and the risk of subsequent development of cardiovascular disease. It is unclear …